Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
38.64
-0.08 (-0.21%)
At close: Aug 15, 2025, 3:44 PM

Cytokinetics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
94.86M 113.02M 65.58M 112.67M
Short-Term Investments
981.16M 501.8M 717M 358.97M
Long-Term Investments
145.06M 40.53M 46.71M 152.05M
Other Long-Term Assets
7.71M 8M 9.69M 7.19M
Receivables
16.65M 1.28M 147K 51.82M
Inventory
n/a n/a -147K n/a
Other Current Assets
15.28M n/a 12.61M n/a
Total Current Assets
1.11B 628.05M 795.19M 535.67M
Property-Plant & Equipment
140.97M 147.74M 163.19M 146.41M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
293.73M 196.26M 219.59M 305.65M
Total Assets
1.4B 824.32M 1.01B 841.32M
Account Payables
20.37M 21.51M 25.61M 21.09M
Deferred Revenue
52.37M n/a n/a 34.37M
Short-Term Debt
11.52M 10.08M 958K 14.86M
Other Current Liabilities
21.11M 39.81M 23.45M -28.25M
Total Current Liabilities
179.67M 102.68M 84.62M 71.86M
Long-Term Debt
645.6M 607.37M 609.62M 142.84M
Other Long-Term Liabilities
599.19M 380.16M 301.55M 183.53M
Total Long-Term Liabilities
1.36B 1.11B 1.04B 525.6M
Total Liabilities
1.54B 1.21B 1.12B 597.46M
Total Debt
788.68M 755.77M 749.34M 269.93M
Common Stock
118K 102K 94K 84K
Retained Earnings
-2.7B -2.11B -1.59B -1.21B
Comprehensive Income
2.4M -10K -3.59M -869K
Shareholders Equity
-135.37M -386.32M -107.9M 243.86M
Total Investments
1.13B 542.33M 763.7M 511.02M